Annual EBIT
-$86.42 M
+$4.67 M+5.13%
31 December 2023
Summary:
CymaBay Therapeutics annual earnings before interest & taxes is currently -$86.42 million, with the most recent change of +$4.67 million (+5.13%) on 31 December 2023. During the last 3 years, it has fallen by -$35.44 million (-69.51%).CBAY EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$36.82 M
-$7.78 M-26.80%
31 December 2023
Summary:
CymaBay Therapeutics quarterly earnings before interest & taxes is currently -$36.82 million, with the most recent change of -$7.78 million (-26.80%) on 31 December 2023. Over the past year, it has dropped by -$7.78 million (-26.80%).CBAY Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$86.42 M
-$14.26 M-19.77%
31 December 2023
Summary:
CymaBay Therapeutics TTM earnings before interest & taxes is currently -$86.42 million, with the most recent change of -$14.26 million (-19.77%) on 31 December 2023. Over the past year, it has dropped by -$14.26 million (-19.77%).CBAY TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CBAY EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +5.1% | -26.8% | -19.8% |
| 3 y3 years | -69.5% | -66.2% | -9.8% |
| 5 y5 years | -19.7% | -32.9% | +10.9% |
CBAY EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | +839.8% | -1066.4% | +3477.2% |
CymaBay Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$86.42 M(-5.1%) | -$36.82 M(+26.8%) | -$86.42 M(+19.8%) |
| Sept 2023 | - | -$29.04 M(-862.2%) | -$72.16 M(+13.1%) |
| June 2023 | - | $3.81 M(-115.6%) | -$63.81 M(-29.9%) |
| Mar 2023 | - | -$24.38 M(+8.1%) | -$91.06 M(-0.0%) |
| Dec 2022 | -$91.09 M(+4.2%) | -$22.56 M(+9.0%) | -$91.09 M(-2.1%) |
| Sept 2022 | - | -$20.69 M(-11.8%) | -$93.02 M(-1.6%) |
| June 2022 | - | -$23.45 M(-3.9%) | -$94.49 M(+0.2%) |
| Mar 2022 | - | -$24.40 M(-0.3%) | -$94.27 M(+7.8%) |
| Dec 2021 | -$87.42 M(+71.4%) | -$24.48 M(+10.5%) | -$87.42 M(+11.1%) |
| Sept 2021 | - | -$22.16 M(-4.6%) | -$78.68 M(+15.8%) |
| June 2021 | - | -$23.22 M(+32.3%) | -$67.94 M(+21.6%) |
| Mar 2021 | - | -$17.55 M(+11.4%) | -$55.88 M(+6.9%) |
| Dec 2020 | -$50.99 M(-50.5%) | -$15.75 M(+37.9%) | -$52.25 M(-15.7%) |
| Sept 2020 | - | -$11.42 M(+2.4%) | -$61.97 M(-20.8%) |
| June 2020 | - | -$11.15 M(-19.9%) | -$78.25 M(-15.6%) |
| Mar 2020 | - | -$13.93 M(-45.3%) | -$92.75 M(-10.0%) |
| Dec 2019 | -$103.08 M(+42.7%) | -$25.47 M(-8.1%) | -$103.08 M(+6.2%) |
| Sept 2019 | - | -$27.71 M(+8.0%) | -$97.06 M(+10.4%) |
| June 2019 | - | -$25.65 M(+5.8%) | -$87.91 M(+10.3%) |
| Mar 2019 | - | -$24.25 M(+24.7%) | -$79.67 M(+10.3%) |
| Dec 2018 | -$72.21 M | -$19.45 M(+4.8%) | -$72.21 M(+25.4%) |
| Sept 2018 | - | -$18.56 M(+6.7%) | -$57.57 M(+22.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2018 | - | -$17.40 M(+3.6%) | -$46.98 M(+22.9%) |
| Mar 2018 | - | -$16.80 M(+249.3%) | -$38.23 M(+44.4%) |
| Dec 2017 | -$26.48 M(+4.5%) | -$4.81 M(-39.7%) | -$26.48 M(-6.4%) |
| Sept 2017 | - | -$7.98 M(-7.7%) | -$28.29 M(+9.4%) |
| June 2017 | - | -$8.65 M(+71.3%) | -$25.85 M(+8.3%) |
| Mar 2017 | - | -$5.05 M(-23.8%) | -$23.86 M(-5.8%) |
| Dec 2016 | -$25.33 M(+73.3%) | -$6.62 M(+19.6%) | -$25.33 M(+4.0%) |
| Sept 2016 | - | -$5.54 M(-16.8%) | -$24.36 M(-0.3%) |
| June 2016 | - | -$6.66 M(+2.1%) | -$24.42 M(+28.8%) |
| Mar 2016 | - | -$6.52 M(+15.3%) | -$18.96 M(+29.7%) |
| Dec 2015 | -$14.62 M(-53.1%) | -$5.65 M(+0.9%) | -$14.62 M(-32.0%) |
| Sept 2015 | - | -$5.60 M(+369.8%) | -$21.50 M(-0.8%) |
| June 2015 | - | -$1.19 M(-45.2%) | -$21.67 M(-7.6%) |
| Mar 2015 | - | -$2.17 M(-82.7%) | -$23.46 M(-24.7%) |
| Dec 2014 | -$31.16 M(+236.9%) | -$12.53 M(+117.2%) | -$31.16 M(+39.4%) |
| Sept 2014 | - | -$5.77 M(+93.4%) | -$22.36 M(+26.5%) |
| June 2014 | - | -$2.98 M(-69.8%) | -$17.68 M(+5.8%) |
| Mar 2014 | - | -$9.88 M(+164.7%) | -$16.71 M(+80.7%) |
| Dec 2013 | -$9.25 M(-11.2%) | -$3.73 M(+243.0%) | -$9.25 M(+67.6%) |
| Sept 2013 | - | -$1.09 M(-46.0%) | -$5.52 M(+24.6%) |
| June 2013 | - | -$2.01 M(-16.6%) | -$4.43 M(+83.4%) |
| Mar 2013 | - | -$2.42 M | -$2.42 M |
| Dec 2012 | -$10.41 M | - | - |
FAQ
- What is CymaBay Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for CymaBay Therapeutics?
- What is CymaBay Therapeutics annual EBIT year-on-year change?
- What is CymaBay Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for CymaBay Therapeutics?
- What is CymaBay Therapeutics quarterly EBIT year-on-year change?
- What is CymaBay Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for CymaBay Therapeutics?
- What is CymaBay Therapeutics TTM EBIT year-on-year change?
What is CymaBay Therapeutics annual earnings before interest & taxes?
The current annual EBIT of CBAY is -$86.42 M
What is the all time high annual EBIT for CymaBay Therapeutics?
CymaBay Therapeutics all-time high annual earnings before interest & taxes is -$9.20 M
What is CymaBay Therapeutics annual EBIT year-on-year change?
Over the past year, CBAY annual earnings before interest & taxes has changed by +$4.67 M (+5.13%)
What is CymaBay Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of CBAY is -$36.82 M
What is the all time high quarterly EBIT for CymaBay Therapeutics?
CymaBay Therapeutics all-time high quarterly earnings before interest & taxes is $3.81 M
What is CymaBay Therapeutics quarterly EBIT year-on-year change?
Over the past year, CBAY quarterly earnings before interest & taxes has changed by -$7.78 M (-26.80%)
What is CymaBay Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of CBAY is -$86.42 M
What is the all time high TTM EBIT for CymaBay Therapeutics?
CymaBay Therapeutics all-time high TTM earnings before interest & taxes is -$2.42 M
What is CymaBay Therapeutics TTM EBIT year-on-year change?
Over the past year, CBAY TTM earnings before interest & taxes has changed by -$14.26 M (-19.77%)